3 news items
Long-Term Data from Mirum's LIVMARLI Studies in ALGS and PFIC Highlighted at EASL Congress
MIRM
6 Jun 24
developments in our focused markets, or adverse developments in the U.S. or global regulatory environment or economies generally; the continued impact of COVID
Long-Term Data from Mirum's LIVMARLI Studies in ALGS and PFIC to be Presented at EASL Congress
MIRM
29 May 24
and prospects, adverse developments in our focused markets, or adverse developments in the U.S. or global regulatory environment or economies generally
Mirum Pharmaceuticals' LIVMARLI Data Showcased at ESPGHAN Annual Meeting
MIRM
18 May 24
focused markets, or adverse developments in the U.S. or global regulatory environment or economies generally; the continued impact of COVID-19 on our
- Prev
- 1
- Next